NFH NYSE
New Frontier Health Corporation
1W: +5.8%
1M: +3.2%
3M: +6.3%
1Y: +41.1%
$11.95
Last traded 2022-01-26 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2.3B
-4.6% ▼
3Y CAGR: +7.3%
Gross Profit
$1.8B
-7.4% ▼
3Y CAGR: +5.0%
Operating Income
-$78M
-378.0% ▼
Net Income
-$506M
-152.2% ▼
EPS (Diluted)
$-3.85
-151.6% ▼
EBITDA
$185M
-36.1% ▼
3Y CAGR: -4.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Revenue | $1.8B | $2.1B | $2.4B | $2.3B |
| YoY Growth | +0.0% | +12.6% | +15.1% | -4.6% |
| Cost of Revenue | $237M | $304M | $382M | $420M |
| Gross Profit | $1.6B | $1.8B | $2.0B | $1.8B |
| Gross Margin | 87.1% | 85.3% | 83.9% | 81.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1.2B | $1.4B | $1.4B | $1.2B |
| Operating Expenses | $1.5B | $1.8B | $2.0B | $1.9B |
| Operating Income | $44M | -$76M | -$16M | -$78M |
| Operating Margin | 2.4% | -3.7% | -0.7% | -3.5% |
| Interest Expense | $13M | $19M | $133M | $264M |
| Income Before Tax | $68M | -$94M | -$132M | -$478M |
| Tax Expense | $67M | $60M | $68M | $28M |
| Net Income | $13M | -$130M | -$200M | -$506M |
| Net Margin | 0.7% | -6.3% | -8.5% | -22.4% |
| EPS (Diluted) | $1.12 | $-3.21 | $-1.53 | $-3.85 |
| EBITDA | $209M | $88M | $302M | $185M |
| Shares Outstanding | 12M | 40M | 131M | 131M |